Summary.-ICRF 159 has been shown to increase the X-radiation sensitivity of exponentially growing EMT6 mouse tumour cells in vitro. This was found only with ICRF 159 exposure times longer than 10 h and only when the drug was given before irradiation. The increase in radiation sensitivity was expressed as a reduction of the shoulder of the radiation survival curve.
PRIOR treatment for 24 h with the antimitotic agent ICRF 159 was found to increase the effects of X-rays on EMT6 cells grown in vitro (Taylor and Bleehen, 1977) . This potentiation was seen to be dependent on the number of proliferating cells in the drug-treated cell population. Cells in the exponential phase of growth when treated with ICRF 159, were found to have a much reduced radiation survivalcurve shoulder.
In this paper we have examined the time course of this effect and investigated interactions between ICRF 159 and repair processes associated with cellular radiation damage.
MATERIALS AND METHODS
The cell line.-The cells used in this study were EMT6/M/CC. Cells were cultured in 35 ml plastic flasks (Nunc U.K. Ltd) containing 5 ml of Eagles MEM supplemented with 20% calf serum and gassed with a mixture of 95% air and 5% Co2. Flasks for exponentialphase cultures were seeded with 3-5 x 104 cells and allowed to grow, undisturbed, for 48 h before treatment began. In all experiments to be described, exponential-phase cultures were used unless otherwise stated.
The in vitro proliferation kinetics of this cell line have been fully described (Twentyman et al., 1975) .
Radiation treatment.-Irradiations were carried out using 250 kV X-rays from a Pantak machine, with a dose rate of about 63 rad/min. The cells were irradiated at room temperature whilst covered with medium and attached to the surface of the flasks. In the split-dose experiments the cells were returned to the incubator between irradiations.
ICRF 159 treatment.-A quantity of ICRF 159 was dissolved in 0-4M HCI to produce a solution 50 x the final concentration required in the culture flasks. This stock solution was sterilized by millipore filtration and 01 ml was then added to each of the experimental flasks. 01 ml of 0-4M HCI was added to control flasks. In all experiments to be described a drug dose of 200 jug/ml was used.
Survival assay.-Immediately after final irradiation or ICRF 159 treatment, the cells were removed from the surface of the flask by 15 min incubation with 0-075% trypsin solution. Two washes were used to ensure adequate removal of the drug. Following resuspension in medium, the cells were counted in a haemocytometer. After the appropriate dilutions were made, the cells were plated into 50 mm plastic culture dishes (Sterilin). These were incubated at 37°C for and 5% CO2 and at high humidity. Survival was determined at the end of this time by fixing and staining the cells and then counting colonies containing 50 or more cells.
RESULTS
All points shown in the Figures represent a surviving fraction estimated from the mean colony count on 4 replicate dishes. The errors associated with individual determinations were small compared with the spread of results between separate determinations. Where sample errors have been shown, these have been calculated from the Poisson variance as described by Boag (1975) . The errors shown in Table I are for the aggregated results and are calculated from the regression analysis. Single-dose radiation response (a) ICRF 159 before irradiation.-In all experiments with pretreatment by ICRF 159, the cells are exposed to the drug before and during irradiation.
We have previously shown that the radiation response of untreated exponential cultures (Fig. 1 ) is characterized by a wide shoulder with a high extrapolation number (n = 51) and a Dq of 509 rad (Taylor and Bleehen, 1977) . A 24 h exposure to ICRF 159 before irradiation ( Fig. 1) reduces the width of the shoulder, giving a lower extrapolation number (n -3) and a reduced Dq (129 rad). If, however, the time of pretreatment with ICRF 159 is reduced to 6 h as in the present series of experiments (Fig. 1) , the observed radiation response is not found to be significantly different from no-drug controls. Neither a 6 h nor a 24 h drug treatment has any significant effect on the slope (Do) of the radiation response curve.
To demonstrate whether ICRF 159 has (200,ug/ml) 24 h before X-irradiation, normalized to unity. Datum points for X-irradiation alone and for 24 h ICRF 159 + X-irradiation curves have been shown in a previous communication (Taylor and Bleehen, 1977 To determine the time sequence of the radiation potentiation, a range ofICRF 159 exposure times (from 1 to 24 h) followed by a single dose of radiation was examined (Fig. 2) . The radiation dose used (675 rad) gave cell survivals on the exponential portion of the control or drug-treated radiation survival curves (Fig. 1) .
The changes in surviving fraction in Fig. 2 , therefore, reflect quantitative changes in the shoulder of the radiationresponse curve. The interrupted line, as before, shows the combined treatment results normalized to account for the drug cytotoxicity. Drug-exposure times of 1-10 h before X-rays appear to have little effect on the radiation response. The normalized surviving fraction declines from 0-25 to 0-17 in this time. However, with pretreatment times from 10 to 16 h an exponential decline in surviving fraction is observed, from 0 17 at 10 h to 0-01 at 16 h. On increasing the drugexposure time from 16 (Table) .
For the 6 h drug exposure, the second of the 2 radiation doses was given at 6 h, the first being given at varying times before, depending on the required interval between the radiation doses. The drug was always present at the time of the first radiation dose. Therefore, the maximum interval between doses examined was 6 h. Cells exposed to ICRF 159 for 24 h were treated similarly, again with a maximum interval of 6 h between radiation doses. Both fractions of the split radiation doses were given within the respective temporal limits of the 2 plateau regions shown in Fig. 2 . The results of these experiments are shown in Fig. 4 .
Recovery was calculated in the following manner. The single radiation dose (D) giving the same surviving fraction as that found from a split-dose regime was calculated from Fig. 1 . This value was then subtracted from the total dose (Dl + D2) given as two fractions. (D1 + D2) -D, therefore, is a measure of recovered dose. The recovered dose was then expressed as a percentage of the appropriate Dq (Table) Percentage recovery -(Di + D2)-D X 100. Dq It is apparent that no reduction in the capacity to repair sub-lethal radiation damage is observed with either a 6-h or a 24 h drug treatment, when compared to controls. Both control and drug-treated cell populations recover -.,80% of their radiation survival-curve shoulder, as measured by Dq, in about 6 h.
Effect of delayed subculture Under certain conditions, repair of sub-lethal radiation damage can be augmented by repair of a second type of radiation damage, that of potentially lethal damage (PLD) (Little et al., 1973) . This can be observed after a single exposure to radiation, when the irradiated cells are subject to conditions which inhibit the normal progression of cells through the proliferative cycle (Phillips and Tolmach, 1966) . This type of radiation repair is not normally found in exponentially growing cells. However, 200 ,ug/ml ICRF 1.59 has been shown to prevent cells from entering mitosis (Taylor and Bleehen, 1977) . The possibility that ICRF 159-treated exponential cells might repair PLD was therefore examined. Fig. 5 shows the effect of delaying subculture for varying times after a single dose of radiation on drug-free cells. As repair of radiation PLD is said to be dose-dependent (Hahn and Little, 1972; Hahn et al., 1973) , this was examined using 3 different doses of radiation, covering 3 log orders of cell kill. As was expected, no repair of PLD was found over the period examined in our exponential cultures. W;rhen cells exposed to IJRF 159 for 24 h before irradiation were similarly examined (Fig. 6) (Taylor and Bleehen, 1977) .
Repair of PLD is found when plateauphase cells are left in the plateau phase of growth after irradiation (Little, 1969; Hahn et al., 1973 Cells left in late plateau phase for 6 h after a radiation dose of 1460 rad showed a 10-fold increase in survival over similar cells subcultured into fresh medium immediately after irradiation (Fig. 7) . Likewise a 24 h ICRF 159 exposure before the irradiation does not appear to inhibit this repair process (Fig. 7) . The drug (Hellmann and -Murkin, 1974; Norpoth et al., 1974) . This has been attributed to the drug's angiometamorphic action. The subsequent increase in blood supply to the tumour might cause an increase in 02 tension in the tumour tissue, therefore presumably decreasing the fraction of radioresistant hypoxic cells (Norpoth et al., 1974) . A further possible mechanism of radiation potentiation by ICRF 159 was demonstrated when the drug was shown to potentiate radiation killing in vitro (Taylor and Bleehen, 1977) .
In this paper we have shown that in vitro radiation potentiation by ICRF 159 is only found when cells are exposed to the drug for more than 10 h before irradiation (Fig. 2) . No such potentiation is found when the drug is administered after irradiation (Fig. 3) . The time sequence of this effect cannot be readily explained. We had thought that it might be due to a drug-induced accumulation of cells in the G2 phase of the cell cycle. If, however, the point of accumulation was particularly sensitive to radiation, a linear decrease in surviving fraction with time would be expected, which would only reach a plateau when all cells had been accumulated in the radiation-sensitive phase. We have previously shown that all cells in an exponentially growing population (mean cell cycle time _ 12 h) have accumulated in G2 after a 12-h drug exposure (Taylor and Bleehen, 1977) . The results in Fig. 2 , therefore, are incompatible with the hypothesis that the points of accumulation and of druginduced radiation sensitivity are one and the same. We are currently engaged in further studies using synchronized cells in an attempt to elucidate the mechanisms involved.
It is clear, however, that when potentiation does occur, it is manifested as a decrease in the radiation survival-curve shoulder (Fig. 1) . This shoulder is known to be associated with the accumulation and repair of sublethal damage (SLD) (Elkind and Sutton, 1959 eventually repair is known to be proportional to the extrapolation number (n) (Hahn and Little, 1972) . Cells cannot A repair more sub-lethal damage than they have the capacity to accumulate (Hahn, 1968) . Expressing the split-dose results as a recovery ratio (Fig. 8) does not take into account the fact that a 24h exposure * to ICRF 159 reduces the magnitude of the radiation survival-curve shoulder ( Fig.  1) and also the extrapolation number (Table) . As Elkind, Sakamoto and Kamper, 1968) . We have also shown that the ability of ICRF 159 to cause cells to accumulate in G2 does not lead to the repair of PLD which might have led to erroneously high estimates for the repair of SLD (Fig. 6) . However, in a system where repair of PLD is possible, prolonged treatment with ICRF 159 has no significant effect on this repair process (Fig. 7) .
In conclusion, it appears that prolonged exposure to ICRF 159 reduces the cellular ability to accumulate sublethal damage. We were unable to show an effect on the repair processes for sub-lethal or potentially lethal radiation damage.
ICRF 159 was kindly supplied to us by Dr A. Creighton and Professor K. Hellmann of the Imperial Cancer Research Fund Laboratories, London.
